<DOC>
	<DOCNO>NCT01088204</DOCNO>
	<brief_summary>The purpose study evaluate oncological feasibility laparoscopy-assisted distal gastrectomy D2 lymph node dissection advance gastric cancer .</brief_summary>
	<brief_title>Feasibility Study Laparoscopy-assisted D2 Distal Gastrectomy Treat Advanced Gastric Cancer</brief_title>
	<detailed_description>To test oncological feasibility , compliance nodal dissection select primary end point . When two miss nodal station ( lymph node dissect area ) , define non-compliant nodal dissection . Other secondary outcome supplementary evaluate feasibility D2 dissection .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>histologically proven primary gastric adenocarcinoma T2 T3 T4a , N0 N1 N2 N3a ( AJCC 7th ) , assess compute tomography ( CT ) scan mid 1/3 low 1/3 location No evidence distant metastasis stump carcinoma , ( vi ) age 2080 year old performance status ( PS ) 0 1 Eastern Cooperative Oncology Group ( ECOG ) scale prior treatment chemotherapy radiation therapy malignancy , prior treatment gastric cancer include endoscopic mucosal resection adequate organ function define indicated : WBC 3000/mm3 , WBC 12 000/mm3 Hb 8.0 g/dl without transfusion 2 week enrollment Plt 100 000/mm3 AST 100 IU/l ALT 100 IU/l T.Bil 2.0 mg/dl write informed consent active double cancer ( synchronous double cancer metachronous double cancer within five diseasefree year ) , exclude carcinoma situ ( lesion equal intraepithelial intramucosal cancer ) pregnant breastfeed woman severe mental disorder systemic administration corticosteroid unstable angina myocardial infarction within 6 month trial unstable hypertension severe respiratory disease require continuous oxygen therapy previous upper abdominal surgery except laparoscopic cholecystectomy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>